Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies

Authors :: Matthew J. Zirwas
Neal Bhatia
Linda Stein Gold
Neil S. Sadick
Edward Lain
Leon H Kircik
Iain Stuart
James Q. Del Rosso
Source :: SKIN The Journal of Cutaneous Medicine. 4:s55
Publication Year :: 2020
Publisher :: National Society for Cutaneous Medicine, 2020.
Abstract: not available.

Subjects :: Moderate to severe
medicine.medical_specialty
Rosacea
business.industry
medicine
Papulopustular rosacea
Minocycline
medicine.disease
business
Dermatology
medicine.drug

Full Text Access

Tools